entyvio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
#updated 1/09/2023 User-agent:* Sitemap: https://www.entyvio.com/sitemap.xml Sitemap: https://www.entyvio.com/image-sitemap.xml Sitemap: https://www.entyvio.com/video-sitemap.xml # End | ||
Meta Tags
| Title | ENTYVIO® (vedolizumab) | Ulcerative Colitis and Crohn’s |
| Description | Uses of ENTYVIO® A treatment for adults with moderate to severe ulcerative colitis or Crohn’s disease. Read about its efficacy, safety, available savings, and more. See Prescribing |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 99.84.160.15 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
entyvio.com Valuation
|
US$233,855,569
Last updated: 2023-05-01 04:58:27
entyvio.com has Semrush global rank of 45,260. entyvio.com has an estimated worth of US$ 233,855,569, based on its estimated Ads revenue. entyvio.com receives approximately 26,983,335 unique visitors each day. Its web server is located in United States, with IP address 99.84.160.15. According to SiteAdvisor, entyvio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$233,855,569 |
| Daily Ads Revenue | US$215,867 |
| Monthly Ads Revenue | US$6,476,001 |
| Yearly Ads Revenue | US$77,712,005 |
| Daily Unique Visitors | 1,798,889 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| entyvio.com. | A | 299 | IP: 99.84.160.15 |
| entyvio.com. | A | 299 | IP: 99.84.160.56 |
| entyvio.com. | A | 299 | IP: 99.84.160.63 |
| entyvio.com. | A | 299 | IP: 99.84.160.60 |
| entyvio.com. | NS | 86400 | NS Record: ns-396.awsdns-49.com. |
| entyvio.com. | NS | 86400 | NS Record: ns-701.awsdns-23.net. |
| entyvio.com. | NS | 86400 | NS Record: ns-1041.awsdns-02.org. |
| entyvio.com. | NS | 86400 | NS Record: ns-1583.awsdns-05.co.uk. |
| entyvio.com. | TXT | 900 | TXT Record: oelr8lgpsk5p8cm9vlakjgkfcj |
HtmlToTextCheckTime:2023-05-01 04:58:27
| Important Safety Information Prescribing Information Medication Guide For Healthcare Professionals Find Follow Watch Home Important Safety Information Prescribing Information Medication Guide For Healthcare Professionals Find Follow Watch Privacy Notice Terms of Use Q&A Site Map Contact Us Unsubscribe Find Follow Watch Click here for information on Coronavirus (COVID-19) Please select your condition Please select your condition Moderate to Severe Ulcerative Colitis Moderate to Severe Crohn’s Disease Uses of ENTYVIO ® (vedolizumab) ENTYVIO is a prescription medicine used in adults for the treatment of: moderately to severely active ulcerative colitis moderately to severely active Crohn’s disease Uses of ENTYVIO ® (vedolizumab) ENTYVIO is a prescription medicine used in adults for the treatment of: moderately to severely active ulcerative colitis moderately to severely active Crohn’s disease Important Safety Information about ENTYVIO ® (vedolizumab) Do not receive ENTYVIO if you have |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Sat, 23 Oct 2021 21:18:23 GMT Content-Type: text/html Content-Length: 183 Connection: keep-alive Location: https://entyvio.com/ X-Cache: Redirect from cloudfront Via: 1.1 6fd3e892e833323ba7dcdc6f465cfe99.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ORD52-C2 X-Amz-Cf-Id: S8T4OsTsD5bYlKPBbuBUZ4EYyfhGziPLNjZFsRBtWlMxS4IhzlHXgg== HTTP/2 302 content-type: text/html; charset=UTF-8 content-length: 147 location: https://www.entyvio.com/ date: Sat, 23 Oct 2021 21:18:23 GMT server: Microsoft-IIS/10.0 x-powered-by: ASP.NET x-cache: Miss from cloudfront via: 1.1 e5ab459dee592201d36b1e9eea4f7329.cloudfront.net (CloudFront) x-amz-cf-pop: ORD53-C1 x-amz-cf-id: KNRQZVergUHvscmDQ0zoQYw1iOX57fSvCW8dpoh9UYzK6zecSdnocw== HTTP/2 200 content-type: text/html; charset=utf-8 content-length: 35473 date: Sat, 23 Oct 2021 21:18:24 GMT set-cookie: AWSALB=YhukB2z28iydUnk9QSf8joGKVrPf66c0slGZLNADTe4ZSQxtn9IfR3YZwEDXzHDMdcZTDi8ubA/G98eYMgA3NH9edYmI2tyFydohO11CW5532BNjUTRBf70IOhDZ; Expires=Sat, 30 Oct 2021 21:18:24 GMT; Path=/ set-cookie: AWSALBCORS=YhukB2z28iydUnk9QSf8joGKVrPf66c0slGZLNADTe4ZSQxtn9IfR3YZwEDXzHDMdcZTDi8ubA/G98eYMgA3NH9edYmI2tyFydohO11CW5532BNjUTRBf70IOhDZ; Expires=Sat, 30 Oct 2021 21:18:24 GMT; Path=/; SameSite=None; Secure cache-control: private server: Microsoft-IIS/10.0 set-cookie: browserUserID=b8aaa681-b953-4925-99e7-d719c88d5029; path=/; HttpOnly set-cookie: UserSegmentation=1; path=/ set-cookie: ASP.NET_SessionId=fapzvtmhkcynr42gdzat4adk; path=/; HttpOnly; SameSite=Lax x-powered-by: ASP.NET x-frame-options: SAMEORIGIN vary: Accept-Encoding x-cache: Miss from cloudfront via: 1.1 160fabe63b184f045d53075e6c659156.cloudfront.net (CloudFront) x-amz-cf-pop: ORD53-C1 x-amz-cf-id: 2Z95CMRnkCxODBjUBvPOcpMaYjHJyWjbV31vJkngzcqPY2zD7KZJ8g== |
entyvio.com Whois Information
Domain Name: ENTYVIO.COM Registry Domain ID: 1666474220_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.1api.net Registrar URL: http://www.1api.net Updated Date: 2021-04-01T07:45:08Z Creation Date: 2011-07-12T05:41:54Z Registry Expiry Date: 2022-07-12T05:41:54Z Registrar: 1API GmbH Registrar IANA ID: 1387 Registrar Abuse Contact Email: abuse@1api.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1041.AWSDNS-02.ORG Name Server: NS-1583.AWSDNS-05.CO.UK Name Server: NS-396.AWSDNS-49.COM Name Server: NS-701.AWSDNS-23.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T06:43:37Z <<< |